Clinical data on the lncATB (Fig. 7a, b) and Twist1 (Fig. 7d, e) expression level revealed that higher expression level observed in triple-negative and Luminal B (Her-2 positive) breast cancer, relative lower level in Luminal A breast cancer, and the lowest level in normal mammary glands. This evidence concerns the gene ERBB2 and breast cancer.